Showing 1,761 - 1,780 results of 151,125 for search '(( a we decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.48s Refine Results
  1. 1761

    Meta data to Fig 5. by Xiaowen Jiang (8291814)

    Published 2024
    “…Using the zebrafish pectoral fin bud as a model for early vertebrate fin/limb development, we found that K<sup>+</sup> channels also scale this anatomical structure, and we determined how one K<sup>+</sup>-leak channel, Kcnk5b, integrates into its developmental program. …”
  2. 1762
  3. 1763

    Table 1_Multi-generational adaptation to Solanum nigrum increases reproduction and decreases microbial diversity of Aphis gossypii.docx by Peng Wang (34436)

    Published 2025
    “…Upon retransferring T1, T5, and the tenth generation of A. gossypii (T10) were retransferred to G. hirsutum (designated as T1-M, T5-M, and T10-M, respectively), the T5-M showed superior r, λ, and fecundity compared to both T1-M and T10-M. 16S rRNA sequencing and qPCR analyses indicated a significant decrease in the diversity of the symbiotic bacterial community in both T5 and T10. …”
  4. 1764

    Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage by Isobel J. Whitehouse (331843)

    Published 2013
    “…Contactin 5 (CNTN5) has also been implicated in the development of AD by a genome-wide association study. …”
  5. 1765

    Statistically significant correspondence between human psoriasis and mouse psoriasiform phenotypes: Proportion of psoriasiform-increased to psoriasiform-decreased transcripts. by William R. Swindell (175427)

    Published 2011
    “…<p>Genes significantly increased or decreased in human psoriasis were identified and the expression of orthologous genes was studied in the K5-Tie2 phenotype (A and B), the IMQ phenotype (C and D), the K14-AREG phenotype on ear skin (E and F), the K14-AREG phenotype on tail skin (G and H), the K5-Stat3C phenotype (I and J), and the K5-TGFβ1 phenotype (K and L). …”
  6. 1766

    Aquaporin 2 Mutations in <i>Trypanosoma brucei gambiense</i> Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol by Fabrice E. Graf (469055)

    Published 2013
    “…Here we describe two different kinds of <i>TbAQP2</i> mutations found in <i>T. b. gambiense</i> field isolates: simple loss of <i>TbAQP2</i>, or loss of wild-type <i>TbAQP2</i> allele combined with the formation of a novel type of <i>TbAQP2/3</i> chimera. …”
  7. 1767

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    “…In an effort to identify an undemetalated client enzyme for the candidate GTPase-powered metallochaperone ZigA, we performed this chemoproteomics experiment in a CP-stressed Δ<i>zigA</i> strain relative the CP-stressed wild-type strain. …”
  8. 1768

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    “…In an effort to identify an undemetalated client enzyme for the candidate GTPase-powered metallochaperone ZigA, we performed this chemoproteomics experiment in a CP-stressed Δ<i>zigA</i> strain relative the CP-stressed wild-type strain. …”
  9. 1769

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    “…In an effort to identify an undemetalated client enzyme for the candidate GTPase-powered metallochaperone ZigA, we performed this chemoproteomics experiment in a CP-stressed Δ<i>zigA</i> strain relative the CP-stressed wild-type strain. …”
  10. 1770

    data_sheet_1_The Reliance on Vestibular Information During Standing Balance Control Decreases With Severity of Vestibular Dysfunction.PDF by Joost van Kordelaar (5333498)

    Published 2018
    “…The vestibular weight during 0.5° peak-to-peak support surface rotations decreased with increasing spontaneous nystagmus eye velocity (ρ = −0.82, p < 0.001). …”
  11. 1771

    data_sheet_2_The Reliance on Vestibular Information During Standing Balance Control Decreases With Severity of Vestibular Dysfunction.PDF by Joost van Kordelaar (5333498)

    Published 2018
    “…The vestibular weight during 0.5° peak-to-peak support surface rotations decreased with increasing spontaneous nystagmus eye velocity (ρ = −0.82, p < 0.001). …”
  12. 1772

    Gas-Phase-like Inertial Rotation of a Platonic Solid in Reticular Amphidynamic Crystals of CUB-5: Molecular Dynamics and Experiment by Jing-Ran Shan (16641931)

    Published 2025
    “…Through quantum mechanical (QM) calculations and molecular dynamics (MD) simulations we verified that nearly barrierless cubane rotators in CUB-5 display rotational dynamics that transitions from continuous or inertial at high temperature, to chaotic behavior, and ultimately to discrete jumps, as the temperature decreases from room temperature down to cryogenic conditions. …”
  13. 1773
  14. 1774

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  15. 1775

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  16. 1776

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  17. 1777

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  18. 1778

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  19. 1779
  20. 1780